FRANKLIN, Tenn.--(BUSINESS WIRE)--BioMimetic Therapeutics, Inc. (NASDAQ: BMTI) announced today that Dr. Charles E. Hart, CSO, will provide an update of corporate activities at the Canaccord Adams 28th Annual Global Growth Conference. The presentation will take place at the Intercontinental Hotel in Boston on Wednesday, August 13 at 4:00 p.m. EDT.
